These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 20921470)
1. Stand and wait. Blackall GF J Clin Oncol; 2010 Dec; 28(34):5124-5. PubMed ID: 20921470 [No Abstract] [Full Text] [Related]
2. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905 [TBL] [Abstract][Full Text] [Related]
3. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation? Aucejo F; Rofaiel G; Miller C J Hepatol; 2006 Jan; 44(1):19-23. PubMed ID: 16298453 [No Abstract] [Full Text] [Related]
8. Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation. Zein NN; Perez RG; Wiesner RH Hepatology; 2000 Mar; 31(3):808-9. PubMed ID: 10722316 [No Abstract] [Full Text] [Related]
9. [Adult posttransplant lymphoproliferative disease: report of 2 cases]. Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1467-8. PubMed ID: 17349170 [No Abstract] [Full Text] [Related]
10. Is hepatitis B virus reactivation a risk factor in the development of posttransplant lymphoproliferative disorder following liver transplantation? Luo Y; Zhang AB; Huang H; Zheng SS Chin Med J (Engl); 2008 Jul; 121(13):1237-40. PubMed ID: 18710646 [No Abstract] [Full Text] [Related]
12. I'm proud to be a nurse. Lyford S Nurs N Z; 2002 Dec; 8(11):26-7. PubMed ID: 12677681 [No Abstract] [Full Text] [Related]
13. Early perioperative death associated with reexpansion pulmonary edema during liver transplantation. Marujo WC; Takaoka F; Moura RM; Pandullo FL; Morrone AR; Linhares MM; Teruya A; Altikes I Liver Transpl; 2005 Nov; 11(11):1439-43. PubMed ID: 16237713 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation in children younger than 1 year--the Cincinnati experience. Tiao GM; Alonso M; Bezerra J; Yazigi N; Heubi J; Balistreri W; Bucuvalas J; Ryckman F J Pediatr Surg; 2005 Jan; 40(1):268-73. PubMed ID: 15868596 [TBL] [Abstract][Full Text] [Related]
15. Lymphoproliferative disorder masquerading as rejection in liver transplant recipients--an early aggressive tumor with atypical presentation. Howard TK; Klintmalm GB; Stone MJ; Cofer JB; Husberg BS; Goldstein RM; Gonwa TA Transplantation; 1992 May; 53(5):1145-7. PubMed ID: 1316652 [No Abstract] [Full Text] [Related]
16. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010 [TBL] [Abstract][Full Text] [Related]
17. Quality of life instruments for liver transplant recipients: too many choices? Kim WR Liver Transpl; 2000 Nov; 6(6):784-5. PubMed ID: 11084069 [No Abstract] [Full Text] [Related]
18. [Lymphoproliferative disease in pediatric liver transplantation]. Martínez Ibáñez V; De Diego M; Allende H; Ruiz-Marcellán C; de Torres I; Español T; Marqués A; Boix-Ochoa J Cir Pediatr; 1994 Oct; 7(4):196-9. PubMed ID: 7865366 [TBL] [Abstract][Full Text] [Related]
19. What is the current treatment of PTLD after liver transplantation? Dufour JF; Fey MF J Hepatol; 2006 Jan; 44(1):23-6. PubMed ID: 16290906 [No Abstract] [Full Text] [Related]
20. Primary nonresponse to anti-cd20 therapy in gastrointestinal posttransplant lymphoproliferative disorder. Gökçe S; Süoğlu OD; Sökücü S; Gün F; Emiroğlu H; Celik A; Doğan O; Cevikbaş U J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):316-20. PubMed ID: 16540802 [No Abstract] [Full Text] [Related] [Next] [New Search]